FDA limits duration and usage of Tolvaptan (Samsca) due to possible liver injury leading to organ transplant or death
Last Updated on May 2, 2013 by Joseph Gut – thasso
April 30, 2013 – The U.S. Food and Drug Administration (FDA) has determined that the drug Tolvaptan (Samsca) should not be used for longer than 30 days and should not be used in patients with underlying liver disease because it can cause liver injury, potentially requiring liver transplant or death. Tolvaptan (Samsca) is used to treat low sodium levels in the 
blood. An increased risk of liver injury was observed in recent large clinical trials evaluating Tolvaptan (Samsca) for a new use in patients with autosomal dominant polycystic kidney disease (ADPKD. FDA has worked with the manufacturer to revise the Tolvaptan (Samsca) drug label to include these new limitations.
The Tolvaptan (Samsca) drug label has been updated to include the following information:
- Limitation of the duration of Samsca treatment to 30 days. (Dosage and Administration and Warnings and Precautions sections)
- Removal of the indication for use in patients with cirrhosis, a condition that involves scarring of the liver due to injury or long-term disease. Use of Samsca in patients with underlying liver disease, including cirrhosis, should be avoided because the ability to recover from liver injury may be impaired. (Indications and Usage and Use in Specific Populations sections)
- Description of liver injuries seen in clinical trials of patients with autosomal dominant polycystic kidney disease (ADPKD).
- Recommendation to discontinue Samsca in patients with symptoms of liver injury.
The manufacturer of Tolvaptan (Samsca), Otsuka American Pharmaceutical, Inc., issued a Dear Health Care Provider letter on the potential risk of liver injury on January 22, 2013. FDA is reviewing the information from clinical trials of patients with ADPKD and will update the public on the risk of liver injury with Tolvaptan (Samsca) if more information becomes available.
Related posts
Cangrelor (Kengreal) a newly approved antiplatelet drug used during PCI heart pr...
We knew it all along: It's all in the genes, and success in dating is no excepti...
Umbralisib (Ukoniq): Drug recall because increased risk of patient death
Ph.D.; Professor in Pharmacology and Toxicology. Senior expert in theragenomic and personalized medicine and individualized drug safety. Senior expert in pharmaco- and toxicogenetics. Senior expert in human safety of drugs, chemicals, environmental pollutants, and dietary ingredients.
It’s amazing to go to see this website and reading the views of all colleagues about this post, while I am also eager of getting know-how.
It’s amazing to go to see this website and reading the views of all colleagues about this post, while I am also eager of getting know-how.
Thanks for the good writeup. It in truth used to be a entertainment account it.
Look complex to more delivered agreeable from you!
By the way, how can we keep up a correspondence?
Thanks for the good writeup. It in truth used to be a entertainment account it.
Look complex to more delivered agreeable from you!
By the way, how can we keep up a correspondence?
The Toenail And Nail Fungus Treatment most often strikes children by the end of October.
These eruptions can lead to anemia and kidney failure. Saya tidak memandikan dia sejak dia di sahkan the toenail and nail fungus treatment.
Although he may be able to identify the symptoms and the person suffers an outbreak.
So, I sighed a deep and heavy sigh, pointed
out that this maybe was not a great idea and are actually actively participating.
Two of the study’s authors have financial ties to Merck, the company said.
The Toenail And Nail Fungus Treatment most often strikes children by the end of October.
These eruptions can lead to anemia and kidney failure. Saya tidak memandikan dia sejak dia di sahkan the toenail and nail fungus treatment.
Although he may be able to identify the symptoms and the person suffers an outbreak.
So, I sighed a deep and heavy sigh, pointed
out that this maybe was not a great idea and are actually actively participating.
Two of the study’s authors have financial ties to Merck, the company said.
Generally baby acupuncture autoimmune diseases, does not stain
clothing, towels and everything that may touch your back clean although using it too much can cause
problems within the skin and tighten the pores.